Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 52
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 26(15): 5380-5392, 2022 08.
Artigo em Inglês | MEDLINE | ID: mdl-35993632

RESUMO

OBJECTIVE: Poncirus trifoliata (P. trifoliata) fruits exert phytotherapeutic effects, depending on their maturity level. However, the mechanism by which these phytotherapeutic effects are exerted remains undefined - especially in cancers. Therefore, in this study, we investigated the effects of the immature fruit extract of P. trifoliata on a B16 melanoma cell line. MATERIALS AND METHODS: The effect of immature P. trifoliata extract on B16 cells was evaluated by MTT assay, cell proliferation, FACScan analysis of cell cycles, confocal imaging analysis, nuclear (Hoechst) staining, apoptosis assay (Annexin V-fluorescein isothiocyanate/propidium iodide staining), and Western blot assay. The capacity of immature P. trifoliata extract to inhibit the invasion and migration of B16 cells was assessed using the scratch-wound assay and Matrigel migration assay. The effect of immature P. trifoliata extract on mitochondrial function was determined via the mitochondrial membrane potential assay, activity, and fraction and cytosol proteins. RESULTS: Treating B16 cells with a methanol extract of immature P. trifoliata (MEPT) significantly inhibited cell viability, migration, and invasiveness in a dose- (p<0.01) and time (p<0.01)- dependent manner. MEPT arrested the cells in the G1 phase of the cell cycle and led to the activation of the PI3K/AKT/p21 pathway. Furthermore, MEPT dose-dependently induced apoptosis in B16 cells by increasing the expression of the pro-apoptotic proteins Bax and Apaf-1, while decreasing the expression of the anti-apoptotic protein, Bcl-2. MEPT treatment also decreased mitochondrial membrane potential. CONCLUSIONS: Immature P. trifoliata extract inhibited the growth of melanoma cells by inducing cell apoptosis through mitochondrial pathways. Therefore, further research into immature P. trifoliata extract as a potential therapeutic compound for melanoma treatment is warranted.


Assuntos
Melanoma , Poncirus , Apoptose , Linhagem Celular Tumoral , Proliferação de Células , Frutas , Humanos , Melanoma/metabolismo , Mitocôndrias/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Extratos Vegetais/farmacologia , Poncirus/metabolismo
2.
Obes Rev ; 19(11): 1585-1596, 2018 11.
Artigo em Inglês | MEDLINE | ID: mdl-30180304

RESUMO

This study aimed to evaluate the effect of acupuncture and intervention types on weight loss. We searched electronic databases, including Embase, PubMed, CENTRAL, RISS, KISS and CNKI, for randomized controlled trials that used acupuncture to treat obesity before June 2017. We found 27 trials involving 32 intervention arms and 2,219 patients. Acupuncture plus lifestyle modification (LM) was more effective than LM alone (Hedges' g = 1.104, 95% CI = 0.531-1.678) and sham acupuncture plus LM (Hedges' g = 0.324, 95% CI = 0.177-0.471), whereas acupuncture alone was not more effective than sham acupuncture alone and no treatment. Auricular acupuncture (Hedges' g = 0.522, 95% CI = 0.152-0.893), manual acupuncture (Hedges' g = 0445, 95% CI = 0.044-0.846) and pharmacopuncture (Hedges' g = 0.411, 95% CI = 0.026-0.796) favoured weight loss. Finally, acupuncture treatment was effective only in subjects with overweight (25 ≤ body mass index < 30, Hedges' g = 0.528, 95% CI = 0.279-0.776), not in subjects with obesity (body mass index ≥30). Our study suggests that the effect of acupuncture on weight loss may be maximized when auricular and manual acupuncture or pharmacopuncture treatment is combined with LM in patients with overweight.


Assuntos
Terapia por Acupuntura , Estilo de Vida , Obesidade/terapia , Redução de Peso , Índice de Massa Corporal , Humanos , Resultado do Tratamento
3.
Thromb Haemost ; 114(2): 258-67, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25925992

RESUMO

Patients on rivaroxaban requiring percutaneous coronary intervention (PCI) represent a clinical conundrum. We aimed to investigate whether rivaroxaban, with or without an additional bolus of unfractionated heparin (UFH), effectively inhibits coagulation activation during PCI. Stable patients (n=108) undergoing elective PCI and on stable dual antiplatelet therapy were randomised (2:2:2:1) to a short treatment course of rivaroxaban 10 mg (n=30), rivaroxaban 20 mg (n=32), rivaroxaban 10 mg plus UFH (n=30) or standard peri-procedural UFH (n=16). Blood samples for markers of thrombin generation and coagulation activation were drawn prior to and at 0, 0.5, 2, 6-8 and 48 hours (h) after start of PCI. In patients treated with rivaroxaban (10 or 20 mg) and patients treated with rivaroxaban plus heparin, the levels of prothrombin fragment 1 + 2 at 2 h post-PCI were 0.16 [0.1] nmol/l (median) [interquartile range, IQR] and 0.17 [0.2] nmol/l, respectively. Thrombin-antithrombin complex values at 2 h post-PCI were 3.90 [6.8]µg/l and 3.90 [10.1] µg/l, respectively, remaining below the upper reference limit (URL) after PCI and stenting. This was comparable to the control group of UFH treatment alone. However, median values for thrombin-antithrombin complex passed above the URL with increasing tendency, starting at 2 h post-PCI in the UFH-alone arm but not in rivaroxaban-treated patients. In this exploratory trial, rivaroxaban effectively suppressed coagulation activation after elective PCI and stenting.


Assuntos
Doença das Coronárias/cirurgia , Inibidores do Fator Xa/uso terapêutico , Intervenção Coronária Percutânea , Complicações Pós-Operatórias/prevenção & controle , Rivaroxabana/uso terapêutico , Trombose/prevenção & controle , Idoso , Anticoagulantes/uso terapêutico , Antitrombina III/análise , Biomarcadores/sangue , Quimioterapia Combinada , Procedimentos Cirúrgicos Eletivos , Inibidores do Fator Xa/administração & dosagem , Feminino , Fibrinolíticos/uso terapêutico , Heparina/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Fragmentos de Peptídeos/análise , Peptídeo Hidrolases/análise , Inibidores da Agregação Plaquetária/uso terapêutico , Cuidados Pós-Operatórios , Complicações Pós-Operatórias/sangue , Protrombina/análise , Fatores de Risco , Rivaroxabana/administração & dosagem , Método Simples-Cego , Stents , Trombina/biossíntese , Trombose/sangue
4.
Skin Pharmacol Physiol ; 27(3): 132-40, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24434642

RESUMO

PURPOSE: Ultraviolet (UV) light from sunlight is an important environmental factor causing hazardous health effects, including various skin disorders. UV irradiation downregulates reactive oxygen species (ROS) elimination pathways, thereby promoting the production of ROS, which are implicated in mitochondria-mediated apoptosis. Walnuts, the seeds of Juglandis sinensis L., are a highly nutritious food and have been shown to have a number of pharmacological activities. To our knowledge, no study on the protective effects of walnuts on human epidermal keratinocytes has been reported previously. Here, we investigated the protective effects of walnuts against UVB (50 mJ/cm(2)) -induced mitochondria-mediated apoptosis. PROCEDURES AND RESULTS: Walnuts significantly and dose-dependently reduced UVB-induced apoptotic toxicity by lactate dehydrogenase assay kit. Walnuts decreased mitochondrial dysfunction, B-cell lymphoma 2 (Bcl-2)-associated X (Bax) protein levels, and cytochrome c release from mitochondria, while increasing Bcl-2 protein levels using immunofluorescence, Western blot, or kit analysis. Moreover, walnuts inhibited caspase-3 activity, indicating an inhibition of the apoptotic cascade, and induced the expression of heme oxygenase and NAD(P)H dehydrogenase via NF-E2-related factor-2 activation using immunofluorescence or Western blot analysis. CONCLUSION: Together, these results demonstrate that walnuts can protect human epidermal keratinocytes against UVB-induced mitochondria-mediated apoptosis by regulating ROS elimination pathways.


Assuntos
Apoptose/efeitos dos fármacos , Juglans/química , Queratinócitos/efeitos dos fármacos , Extratos Vegetais/farmacologia , Apoptose/efeitos da radiação , Western Blotting , Caspase 3/metabolismo , Linhagem Celular , Citocromos c/metabolismo , Relação Dose-Resposta a Droga , Epiderme/efeitos dos fármacos , Epiderme/efeitos da radiação , Imunofluorescência , Humanos , Queratinócitos/patologia , Queratinócitos/efeitos da radiação , L-Lactato Desidrogenase/metabolismo , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/patologia , Mitocôndrias/efeitos da radiação , Extratos Vegetais/administração & dosagem , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Sementes , Raios Ultravioleta/efeitos adversos , Regulação para Cima/efeitos dos fármacos , Proteína X Associada a bcl-2/metabolismo
5.
J Evol Biol ; 26(6): 1341-52, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23517061

RESUMO

Environmental inputs during early development can shape the expression of phenotypes, which has long-lasting consequences in physiology and life history of an organism. Here, we study whether experimentally manipulated availability of dietary antioxidants, vitamins C and E, influences the expression of genetic variance for antioxidant defence, endocrine signal and body mass in yellow-legged gull chicks using quantitative genetic models based on full siblings. Our experimental study in a natural population reveals that the expression of genetic variance in total antioxidant capacity in plasma increased in chicks supplemented with vitamins C and E despite the negligible effects on the average phenotype. This suggests that individuals differ in their ability to capture and transport dietary antioxidants or to respond to these extra resources, and importantly, this ability has a genetic basis. Corticosterone level in plasma and body mass were negatively correlated at the phenotypic level. Significant genetic variance of corticosterone level appeared only in control chicks nonsupplemented with vitamins, suggesting that the genetic variation of endocrine system, which transmits environmental cues to adaptively control chick development, appeared in stressful conditions (i.e. poor antioxidant availability). Therefore, environmental inputs may shape evolutionary trajectories of antioxidant capacity and endocrine system by affecting the expression of cryptic genetic variation.


Assuntos
Antioxidantes/metabolismo , Aves/genética , Variação Genética , Estresse Fisiológico , Vitaminas/metabolismo , Animais , Aves/crescimento & desenvolvimento , Peso Corporal , Corticosterona/sangue , Peroxidação de Lipídeos , Estresse Oxidativo , Espécies Reativas de Oxigênio/metabolismo
6.
Ann Oncol ; 24(2): 489-494, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23110809

RESUMO

BACKGROUND: We evaluated whether complementary and alternative medicine (CAM) use influenced outcomes [survival and health-related quality of life (HRQOL)] of cancer patients whose condition had just been judged terminal. PATIENTS AND METHODS: From July 2005 to October 2006, we conducted a prospective cohort study of 481 terminally ill cancer patients at 11 university hospitals and the National Cancer Center in Korea. We assessed how the use of CAM affected HRQOL and survival. RESULTS: In a follow-up of 481 patients and 163.8 person-years, we identified 466 deceased cases. On multivariate analyses, CAM users did not have better survival compared with nonusers [adjusted hazard ratio (aHR), 0.91; 95% confidence interval (CI) 0.74-1.10]. Among mind-body interventions, prayer showed significantly worse survival (aHR, 1.56; 95% CI, 1.00-2.43). Clinically, CAM users reported significantly worse cognitive functioning (-11.6 versus -1.3; P < 0.05) and fatigue (9.9 versus -1.0; P < 0.05) than nonusers. Compared with nonusers in subgroup analysis, users of alternative medical treatments, prayer, vitamin supplements, mushrooms, or rice and cereal reported clinically significant worse changes in some HRQOL subscales. CONCLUSION: While CAM did not provide any definite survival benefit, CAM users reported clinically significant worse HRQOLs.


Assuntos
Terapias Complementares , Neoplasias/terapia , Qualidade de Vida , Doente Terminal , Idoso , Estudos de Coortes , Terapias Complementares/psicologia , Feminino , Nível de Saúde , Humanos , Masculino , Neoplasias/mortalidade , Neoplasias/psicologia , Estudos Prospectivos , Inquéritos e Questionários , Taxa de Sobrevida , Resultado do Tratamento
7.
Transplant Proc ; 44(4): 1180-2, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22564659

RESUMO

An 8-year-old girl was admitted for severe electrolyte imbalance and for hyponatremic seizure. In July 2005, at 3 years of age, she underwent isolated small-bowel transplantation of 100 cm ileum from her father. Her own bowel was only 50 cm of proximal jejunum which had been directly connected to the anus due to extended total aganglionosis. The graft was placed into the middle of her remaining bowel, using the splenic artery and vein as feeding vessels with saving of the spleen. Daclizumab induction and tacrolimus monotherapy were applied for immunosuppression. Two acute cellular rejection episodes, E on day 10 and 4 years after transplantation, were successfully treated with OKT-3 and recombinant antithymocyte globulin, respectively. However, because of intermittent bowel dysfunction, she was hospitalized several times for hydration and metabolic care. On admission, her abdomen was moderately distended, and a simple abdominal film showed a fixed dilated loop. Colonoscopy could not pass the narrowed lumen, with stiffness at the anastomosis between the graft and the distal bowel. Endoscopic biopsy at the entrance to the stricture showed a nonspecific inflammatory reaction with fibrosis. Similar findings on a gastrograffin enema suggested chronic rejection (CR). On laparotomy, an irregularly narrowed fibrotic loop was noticed at the distal part of the graft, proximal to the anastomosis. We performed a 20-cm segmental resection with an end-to-end anastomosis. Histopathologic findings showed CR with fibrosis and hyalinization of the entire bowel wall and vessel walls with mild cellular infiltrations. She recovered in 10 days. The graft may have been saved, but intermittent requirement of hydration over the following months suggested progressive graft dysfunction. A case of segmental involvement of CR with subsequent successful graft salvage by partial resection is rare in the literature.


Assuntos
Rejeição de Enxerto/cirurgia , Íleo/transplante , Jejuno/cirurgia , Transplante de Órgãos/efeitos adversos , Síndrome do Intestino Curto/cirurgia , Biópsia , Pré-Escolar , Doença Crônica , Pai , Feminino , Fibrose , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/patologia , Humanos , Íleo/imunologia , Íleo/patologia , Imunossupressores/uso terapêutico , Jejuno/imunologia , Jejuno/patologia , Doadores Vivos , Masculino , Reoperação , Fatores de Tempo , Resultado do Tratamento
8.
Skin Pharmacol Physiol ; 25(2): 93-9, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22301773

RESUMO

BACKGROUND: Oxidative radicals are major environmental causes of human skin damage. Oxidative defense factors, including nuclear factor erythroid-derived 2-related factor 2 (Nrf2), are centrally involved in repairing skin cells or protecting them from oxidative damage. Coriandrum sativum L. (coriander; CS) is a commonly consumed food and a traditional phytomedicine in Asia and Europe. In this study, we examined the protective effects of a standardized CS leaf extract against oxidative stress in human HaCaT keratinocytes. METHODS AND RESULTS: CS significantly and dose-dependently protected cells against reduced cell viability caused by H2O2-induced damage, as assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Other assays demonstrated that CS protected HaCaT cells by increasing the levels of glutathione and activities of oxidative defense enzymes, such as superoxide dismutase and catalase. Moreover, it increased the expression of activated Nrf2, which plays a crucial role in protecting skin cells against oxidative stress. CONCLUSION: These results suggest that CS protects human keratinocytes from H2O2-induced oxidative stress through antioxidant effects.


Assuntos
Coriandrum/química , Queratinócitos/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/farmacologia , Antioxidantes/metabolismo , Catalase/metabolismo , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Glutationa/metabolismo , Humanos , Peróxido de Hidrogênio/toxicidade , Queratinócitos/metabolismo , Medicina Tradicional , Fator 2 Relacionado a NF-E2/metabolismo , Extratos Vegetais/administração & dosagem , Superóxido Dismutase/efeitos dos fármacos , Superóxido Dismutase/metabolismo
9.
Pharmazie ; 67(12): 1007-9, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23346764

RESUMO

Ginger has been extensively used as a herbal medicine for thousands of years in Asia; it has also been used as a seasoning agent in several foods and beverages worldwide. In this study, the effect of an aqueous-ethanolic extract of ginger on CYP450-mediated drug metabolism was investigated in vitro to elucidate the herb-drug interactions. A CYP450-specific substrates mixture was incubated with an aqueous-ethanolic extract of ginger in human liver microsomes fortified with an NADPH-generating system, and the metabolites generated from each of the CYP450-specific metabolic reactions were measured by liquid chromatography-tandem mass spectrometry. The ginger extracts were tested at concentrations of 0.05-5 microg/mL. The resulting data showed that the ginger extract inhibited CYP2C19-mediated drug metabolism in a concentration-dependent manner with an IC50 value of 3.8 microg/mL. When the ginger extract was pre-incubated and assessed, the inhibition pattern did not change, indicating that the inhibition of CYP2C19 was competitive rather than mechanism-based. The effects on other CYP isozyme activity were negligible at the concentrations tested. In conclusion, this inhibitory effect of ginger extract could affect the pharmacokinetics and lead to interactions with drugs that are metabolized by CYP2C19.


Assuntos
Sistema Enzimático do Citocromo P-450/metabolismo , Preparações Farmacêuticas/metabolismo , Zingiber officinale/química , Cromatografia Líquida de Alta Pressão , Inibidores das Enzimas do Citocromo P-450 , Inibidores Enzimáticos/farmacologia , Etanol , Humanos , Técnicas In Vitro , Isoenzimas/antagonistas & inibidores , Isoenzimas/metabolismo , Espectrometria de Massas , Microssomos Hepáticos/metabolismo , Extratos Vegetais/farmacologia , Solventes , Espectrometria de Massas por Ionização por Electrospray , Água
10.
Int J Sports Med ; 32(12): 929-34, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22052030

RESUMO

The purpose of this study was to investigate the effect of sprint interval training (SIT) compared to control group (CG). 29 Judoists were assigned to SIT group (n=11, age 20.00±1.10 years) and CG (n=18, age 19.94±1.16 years). There were no significant changes in body fat and aerobic performance (VO2max, HRmax, and HR after Judo match) after 4 and 8 weeks. However, anaerobic peak power and mean power in SIT group was significantly increased by 16% and 17% at 4 weeks and by 17% and 22% at 8 weeks compared to baseline values (p<0.05). At 8 weeks, blood lactate concentration after graded exercise was significantly decreased in SIT group compared to CG after 10 and 15 min of recovery (p< 0.05). After Judo match, triglyceride and epinephrine were significantly increased in CG compared to SIT group (p<0.05) at 4 and 8 weeks. Otherwise, there were no significant changes of total cholesterol, albumin, FFA, and norepinephrine in both groups. We suggested that SIT program for elite Judoists would be effective to increase anaerobic power in a short period during off-season training.


Assuntos
Limiar Anaeróbio/fisiologia , Composição Corporal/fisiologia , Exercício Físico/fisiologia , Artes Marciais/fisiologia , Corrida/fisiologia , Tecido Adiposo , Análise de Variância , Peso Corporal/fisiologia , Teste de Esforço , Humanos , Contração Isométrica/fisiologia , Ácido Láctico/sangue , Masculino , Consumo de Oxigênio/fisiologia , Adulto Jovem
11.
BJOG ; 118(8): 899-915, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21609380

RESUMO

BACKGROUND: Although acupuncture is widely applied in obstetrics and gynaecology, evidence for its efficacy in treating premenstrual syndrome (PMS) is equivocal. OBJECTIVE: To summarise and evaluate the current evidence for acupuncture as a treatment for PMS. SEARCH STRATEGY: Ten databases were searched electronically, and relevant reviews were searched by hand through June 2009. SELECTION CRITERIA: Our review included randomised controlled trials (RCTs) of women with PMS; these RCTs compared acupuncture with sham acupuncture, medication, or no treatment. DATA COLLECTION AND ANALYSIS: Study outcomes were presented as mean differences (for continuous data) or risk ratios (RRs) (for dichotomous data) with a 95% confidence interval (95% CI). The risk of bias was assessed using the assessment tool from the Cochrane Handbook. MAIN RESULTS: Ten RCTs were included in our review. The pooled results demonstrated that acupuncture is superior to all controls (eight trials, pooled RR 1.55, 95% CI 1.33-1.80, P < 0.00001). A meta-analysis comparing the effects of acupuncture with different doses of progestin and/or anxiolytics supported the use of acupuncture (four trials, RR 1.49, 95% CI 1.27-1.74, P < 0.00001). In addition, acupuncture significantly improved symptoms when compared with sham acupuncture (two trials, RR 5.99, 95% CI 2.84-12.66, P < 0.00001). No evidence of harm resulting from acupuncture emerged. Most of the included studies demonstrated a high risk of bias in terms of random sequence generation, allocation concealment, and blinding. AUTHOR'S CONCLUSIONS: Although acupuncture seems promising for symptom improvement in women with PMS, important methodological flaws in the included studies weaken the evidence. Considering the potential of acupuncture, further rigorous studies are needed.


Assuntos
Terapia por Acupuntura , Síndrome Pré-Menstrual/terapia , Feminino , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Resultado do Tratamento
12.
J Dairy Sci ; 93(8): 3610-5, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20655430

RESUMO

Lantibiotics are small (<5 kDa), polycyclic peptides produced by gram-positive bacteria; they are also known as gram-positive bacteriocins. The high antimicrobial activity of lacticins and the continuing appearance of antibiotic-resistant bacteria in recent years have resulted in a renewed interest in lantibiotics. A partially purified form of lacticin NK34 (a Lactococcus lactis product isolated from the Korean fermented fish jeotgal) was tested to determine its antimicrobial effects against Staphylococcus aureus (n=20) and coagulase-negative Staphylococcus (CNS, n=20) strains isolated from the raw milk of cows with subclinical bovine mastitis in the present study. The spot-on-lawn assay was used to identify the 2 strains from each group with the greatest lacticin NK34 susceptibility, and the minimal lethal dose (MLD) was measured in ICR (imprinting control region) mice. The preventive and therapeutic effects of lacticin NK34 on the mouse infection model were determined for the first time. Lacticin NK34 demonstrated antimicrobial effects in 14 of 20 (70%) S. aureus indicator strains and in 18 of 20 (90%) CNS strains. Staphylococcus aureus 69 and S. simulans 55 demonstrated the greatest susceptibility to lacticin NK34 in the spot-on-lawn assay. The S. aureus 69 MLD was measured at 1.53 x 10(9) cfu/mouse, whereas the S. simulans 55 MLD was 3.59 x 10(9) cfu/mouse. Mice infected experimentally with S. aureus 69 MLD or S. simulans 55 MLD were treated with lacticin NK34. Treated mice demonstrated an 80% survival rate (48 of 60 mice) compared with a survival rate of 7.5% (3 of 40 mice) in control mice treated with distilled water. These data suggest that lacticin NK34 might be useful in the control of bovine mastitis and systemic bacterial infection.


Assuntos
Antibacterianos/uso terapêutico , Bacteriocinas/uso terapêutico , Mastite Bovina/prevenção & controle , Infecções Estafilocócicas/veterinária , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus/efeitos dos fármacos , Animais , Bovinos , Técnicas de Cultura , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos/veterinária , Feminino , Lactococcus lactis/metabolismo , Mastite Bovina/microbiologia , Camundongos , Leite/microbiologia , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/prevenção & controle , Staphylococcus/isolamento & purificação , Staphylococcus aureus/isolamento & purificação
13.
Br J Anaesth ; 103(5): 750-4, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19797249

RESUMO

BACKGROUND: The administration of low-dose bupivacaine can limit the distribution of spinal block to reduce adverse haemodynamic effects. Intrathecal opioids can enhance analgesia in combination with subtherapeutic doses of local anaesthetics. We aimed at comparing the efficacy of intrathecal fentanyl and sufentanil with low-dose diluted bupivacaine for transurethral prostatectomy (TURP) in elderly patients. METHODS: Seventy patients undergoing TURP were randomly allocated into two groups. Group F (n=35) received fentanyl 25 microg+bupivacaine 0.5% (0.8 ml)+normal saline 0.3 ml and Group S (n=35) received sufentanil 5 microg+bupivacaine 0.5% (0.8 ml)+normal saline 0.7 ml--in total, bupivacaine 0.25% (1.6 ml) intrathecally. Onset and duration of the sensory block, the degree of the motor block, side-effects, and the perioperative analgesic requirements were assessed. RESULTS: The median peak level of the sensory block was significantly higher in Group S than in Group F (P=0.049). Group S required fewer perioperative analgesics than Group F (P=0.008). The time to the first analgesic request was longer in Group S (P=0.025). There were no differences between the groups for the onset and recovery time of the sensory block, degree of the motor block, quality of anaesthesia, or adverse effects. CONCLUSIONS: Low-dose diluted bupivacaine with fentanyl 25 microg or sufentanil 5 microg can provide adequate anaesthesia without haemodynamic instability for TURP in elderly patients. However, sufentanil was superior to fentanyl in the quality of the spinal block produced.


Assuntos
Adjuvantes Anestésicos/administração & dosagem , Raquianestesia/métodos , Fentanila/administração & dosagem , Sufentanil/administração & dosagem , Ressecção Transuretral da Próstata , Idoso , Idoso de 80 Anos ou mais , Anestésicos Locais/administração & dosagem , Bupivacaína/administração & dosagem , Método Duplo-Cego , Humanos , Masculino , Pessoa de Meia-Idade , Hiperplasia Prostática/cirurgia
14.
Phytother Res ; 22(11): 1417-22, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18972585

RESUMO

To investigate the effects of yeast hydrolysate on appetite regulation mechanisms in the central nervous system, nitric oxide synthase (NOS) expression and vasoactive intestinal peptide (VIP) immunoreactivity in the paraventricular nucleus (PVN) and ventromedial hypothalamic nucleus (VMH) of the hypothalamus were examined. Male Sprague-Dawley (SD) rats were assigned to five groups: control (normal diet), BY-1 and BY-2 (normal diet with oral administration of 0.1 g and 1.0 g of yeast hydrolysate <10 kDa/kg body weight, respectively), AY-1 and AY-2 (normal diet with oral administration of 0.1 g and 1.0 g of yeast hydrolysate 10-30 kDa/kg body weight, respectively). The body weight gain in the BY groups was less than that in the control. In particular, the weight gain of the BY-2 group (133.0 +/- 5.1 g) was significantly lower (p < 0.05) than that of the control group (150.1 +/- 3.7 g). Among the test groups, the BY-2 group was shown to have significantly lower triacylglycerol (TG) levels (p < 0.05) than the other groups. The staining intensities and optical densities of NOS neurons in the PVN of the AY group were significantly higher (p < 0.05) than in the control and BY groups. The staining intensities and optical densities of VIP immunoreactivity in the PVN and VMH of the BY groups were higher than those of the AY groups and the control. In conclusion, these results indicated that yeast hydrolysate of <10 kDa reduced the body weight gain and body fat in normal diet-fed rats and increased the lipid energy metabolism by altering the expression of NOS and VIP in neurons.


Assuntos
Depressores do Apetite/farmacologia , Óxido Nítrico Sintase/metabolismo , Núcleo Hipotalâmico Paraventricular/metabolismo , Peptídeo Intestinal Vasoativo/metabolismo , Núcleo Hipotalâmico Ventromedial/metabolismo , Fermento Seco/farmacologia , Análise de Variância , Animais , Imuno-Histoquímica , Lipídeos/sangue , Masculino , Óxido Nítrico Sintase/efeitos dos fármacos , Núcleo Hipotalâmico Paraventricular/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Peptídeo Intestinal Vasoativo/efeitos dos fármacos , Núcleo Hipotalâmico Ventromedial/efeitos dos fármacos , Aumento de Peso
15.
Br J Pharmacol ; 154(5): 1073-8, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18536755

RESUMO

BACKGROUND AND PURPOSE: Recently, we reported that 12(S)-HPETE (12(S)-hydroperoxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid) induces scratching in ICR mice. We hypothesized that 12(S)-HPETE might act as an agonist of the low-affinity leukotriene B4 receptor BLT2. To confirm the involvement of the BLT2 receptor in 12(S)-HPETE-induced scratching, we studied the scratch response using the BLT2 receptor agonists compound A (4'-[[pentanoyl (phenyl) amino]methyl]-1,1'-biphenyl-2-carboxylic acid) and 12(S)-HETE (12(S)-hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid). EXPERIMENTAL APPROACH: A video recording was used to determine whether the BLT2 receptor agonists caused itch-associated scratching in ICR mice. Selective antagonists and several chemicals were used. KEY RESULTS: Both 12(S)-HETE and compound A dose dependently induced scratching in the ICR mice. The dose-response curve for compound A showed peaks at around 0.005-0.015 nmol per site. Compound A- and 12(S)-HETE-induced scratching was suppressed by capsaicin and naltrexon. We examined the suppressive effects of U75302 (6-[6-(3-hydroxy-1E,5Z-undecadienyl)-2-pyridinyl]-1,5-hexanediol, the BLT1 receptor antagonist) and LY255283 (1-[5-ethyl-2-hydroxy-4-[[6-methyl-6-(1H-tetrazol-5-yl)heptyl]oxy]phenyl]-ethanone, the BLT2 receptor antagonist) on the BLT2 agonist-induced scratching. LY255283 suppressed compound A- and 12(S)-HETE-induced scratching, but U75302 did not. LY255283 required a higher dose to suppress the compound A-induced scratching than it did to suppress the 12(S)-HETE-induced scratching. One of the BLT(2) receptor agonists, 12(R)-HETE (12(R)-hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid), also induced scratching in the ICR mice. CONCLUSIONS AND IMPLICATIONS: Our present results corroborate the hypothesis that the BLT2 receptor is involved in 12(S)-lipoxygenase-product-induced scratching in ICR mice. We also confirmed that this animal model could be a valuable means of evaluating the effects of BLT2 receptor antagonists.


Assuntos
Araquidonato 12-Lipoxigenase/metabolismo , Comportamento Animal , Prurido/metabolismo , Receptores do Leucotrieno B4/metabolismo , Ácido 12-Hidroxi-5,8,10,14-Eicosatetraenoico/metabolismo , Animais , Antipruriginosos/farmacologia , Comportamento Animal/efeitos dos fármacos , Capsaicina/farmacologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos/métodos , Álcoois Graxos/farmacologia , Glicóis/farmacologia , Masculino , Camundongos , Camundongos Endogâmicos ICR , Naltrexona/farmacologia , Prurido/induzido quimicamente , Prurido/prevenção & controle , Receptores do Leucotrieno B4/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Tetrazóis/farmacologia , Gravação em Vídeo
16.
J Bone Joint Surg Br ; 87(6): 776-80, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15911657

RESUMO

We performed 114 consecutive primary total hip arthroplasties with a cementless expansion acetabular component in 101 patients for advanced osteonecrosis of the femoral head. The mean age of the patients at surgery was 51 years (36 to 62) and the mean length of follow-up was 110 months (84 to 129). The mean pre-operative Harris hip score of 47 points improved to 93 points at final follow-up. The polyethylene liner was exchanged in two hips during this period and one broken acetabular component was revised. The mean linear wear rate of polyethylene was 0.07 mm/year and peri-acetabular osteolysis was seen in two hips (1.9%). Kaplan-Meier analysis indicated that the survival of the acetabular component without revision was 97.8% (95% confidence interval 0.956 to 1.000) at ten years. Our study has shown that the results of THA with a cementless expansion acetabular component and an alumina-polyethylene bearing surface are good.


Assuntos
Artroplastia de Quadril/métodos , Necrose da Cabeça do Fêmur/cirurgia , Prótese de Quadril , Acetábulo , Adulto , Óxido de Alumínio , Cimentos Ósseos , Feminino , Seguimentos , Articulação do Quadril/diagnóstico por imagem , Humanos , Masculino , Pessoa de Meia-Idade , Polietileno , Complicações Pós-Operatórias/diagnóstico por imagem , Desenho de Prótese , Falha de Prótese , Radiografia , Resultado do Tratamento
17.
Ann Hematol ; 83(12): 733-8, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15372203

RESUMO

Mesenchymal progenitor or stem cells (MPCs) isolated from fetal blood, liver, and bone marrow are a population of multipotential cells that can proliferate and differentiate into multiple mesodermal tissues including bone, cartilage, muscle, ligament, tendon, fat, and stroma. The objective of this study was to isolate and characterize MPCs in the human umbilical cord. The suspensions of endothelial and subendothelial cells in cord vein were collected and cultured in M199 supplemented with 10% fetal bovine serum (FBS). Of 50 umbilical cord samples, 3 had numerous fibroblastoid cells morphologically distinguishable from endothelial cells. Fibroblastic cells displayed lack of expression of vWF, Flk-1, and PECAM-1, indicating the endothelial cell-specific marker. To investigate the differentiation potentials, the cells were cultured in adipogenic or osteogenic medium for 2 weeks. Fibroblast-like cells treated with adipogenic supplementation showed Oil red O-positive staining and expressed adipsin, FABP4, LPL, and PPARgamma2 genes by reverse transcriptase polymerase chain reaction (RT-PCR). In osteogenic differentiation, alkaline phosphatase activity and calcium accumulation were detected. RT-PCR studies determined that Cx43, osteopontin, and Runx2 genes were expressed in the osteogenic cultures. Among three cell lines cultured continuously for passage 10, two had normal karyotypes; however, one retained a karyotype of mos 46,XY[19]/47,XY,+mar[3]. These observations suggest that MPCs are present in human umbilical cord and possess several typical traits of MPCs.


Assuntos
Células-Tronco Mesenquimais/fisiologia , Veias Umbilicais/citologia , Adipócitos/citologia , Adipócitos/fisiologia , Antígenos de Diferenciação/biossíntese , Células da Medula Óssea/citologia , Diferenciação Celular/fisiologia , Células Cultivadas , Células Endoteliais/citologia , Feminino , Sangue Fetal/citologia , Fibroblastos/citologia , Fibroblastos/fisiologia , Humanos , Células-Tronco Mesenquimais/citologia , Mesoderma/citologia , Osteogênese/fisiologia , Gravidez , Veias Umbilicais/fisiologia
18.
J Ethnopharmacol ; 77(2-3): 183-8, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11535362

RESUMO

Based on the use of Scutellaria baicalensis for the treatment of stroke in traditional Oriental medicine, the current study was carried out to evaluate neuroprotective effects of S. baicalensis after transient global ischemia using rat 4-vessel occlusion model. Methanol extracts from the dried roots of S. baicalensis (0.1-10 mg/kg) administered intra-peritoneally significantly protected CA1 neurons against 10 min transient forebrain ischemia as demonstrated by measuring the density of neuronal cells stained with Cresyl violet. Methanol extract of S. baicalensis inhibited microglial tumor necrosis factor-alpha (TNF-alpha) and nitric oxide production, and protected PC12 cells from hydrogen peroxide-induced toxicity in vitro.


Assuntos
Isquemia Encefálica/prevenção & controle , Flavanonas , Flavonoides/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Fitoterapia , Extratos Vegetais/uso terapêutico , Animais , Isquemia Encefálica/patologia , Flavonoides/isolamento & purificação , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Masculino , Fármacos Neuroprotetores/isolamento & purificação , Óxido Nítrico/metabolismo , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/biossíntese
19.
Biol Pharm Bull ; 24(8): 921-4, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11510486

RESUMO

Aster scaber T. (Asteraceae) has been used to treat bruises, snakebite, headache, and dizziness in traditional Chinese medicine. In the present study, the neuroprotective effect of four quinic acid derivatives from A. scaber on amyloid Abeta-induced PC12 cell toxicity was investigated. When cells were treated with quinic acid derivatives prior to Abeta, cell toxicity was significantly diminished. Among quinic acid derivatives, (-)4,5-dicaffeoyl quinic acid (1) gave the highest protection against Abeta-induced cell toxicity. In addition, the neurotrophic effects of compounds were evaluated by microscopically monitoring their potency to induce neurite outgrowth in PC12 cells. Four quinic acid derivatives from A. scaber promoted neurite outgrowth in PC12 cells. Interestingly, a novel quinic acid, (-)3,5-dicaffeoyl-muco-quinic acid (2) was more effective than the other compounds in promoting neurite outgrowth. Unlike nerve growth factor, the withdrawal of quinic acids did not result in any significant decrease in cell viability. The results suggest that quinic acid derivatives from A. scaber might potentially be used as a therapeutic agent in Alzheimer disease.


Assuntos
Asteraceae/química , Fármacos Neuroprotetores/farmacologia , Nootrópicos/farmacologia , Ácido Quínico/farmacologia , Peptídeos beta-Amiloides/metabolismo , Animais , Sobrevivência Celular , Fator de Crescimento Neural/deficiência , Neuritos/efeitos dos fármacos , Neuritos/ultraestrutura , Células PC12 , Ratos
20.
Neurosci Lett ; 309(1): 67-71, 2001 Aug 17.
Artigo em Inglês | MEDLINE | ID: mdl-11489548

RESUMO

Flavonoids are a group of low molecular weight polyphenolic compounds derived from plants. 5,7-dihydroxy-8-methoxyflavone (Wogonin), a flavonoid originated from the root of Scutellaria baicalensis Georgi, has been shown to exert various anti-inflammatory effects such as inhibition of nitric oxide (NO) and prostaglandin E2 production in macrophages. Because glial cells have been previously shown to undergo NO-dependent apoptosis upon inflammatory activation and this auto-regulatory process may be negatively affected by exogenous factors possessing anti-inflammatory activities, we examined the effects of wogonin on NO production and activation-induced cell death of C6 rat glial cells. Activation of C6 glial cells with lipopolysaccharide (LPS), interferon-gamma, and tumor necrosis factor-alpha induced NO production followed by cell death. Pretreatment of C6 cells with wogonin before LPS and cytokine treatment dose-dependently inhibited NO production as well as death of activated C6 cells. Wogonin-mediated inhibition of NO production was accompanied by suppression of inducible nitric oxide synthase (iNOS) protein induction and nuclear factor kappa B (NF-kappaB) reporter activity. Wogonin, however, did not affect a NO donor-induced cytotoxicity. Taken together, our results indicate that wogonin inhibits activation-induced death of C6 glial cells by suppressing NO production, and these inhibitory effects of wogonin on NO production are exerted through inhibition of NF-kappaB-mediated iNOS induction.


Assuntos
Apoptose/efeitos dos fármacos , Células Cultivadas/efeitos dos fármacos , Encefalite/tratamento farmacológico , Flavanonas , Flavonoides/farmacologia , Sequestradores de Radicais Livres/farmacologia , Neuroglia/efeitos dos fármacos , Óxido Nítrico/biossíntese , Animais , Apoptose/fisiologia , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Células Cultivadas/metabolismo , Diploide , Relação Dose-Resposta a Droga , Medicamentos de Ervas Chinesas/farmacologia , Encefalite/metabolismo , Encefalite/fisiopatologia , Inibidores Enzimáticos/farmacologia , Interferon gama/farmacologia , Lipopolissacarídeos/farmacologia , NF-kappa B/efeitos dos fármacos , NF-kappa B/metabolismo , Doenças Neurodegenerativas/tratamento farmacológico , Doenças Neurodegenerativas/etiologia , Doenças Neurodegenerativas/fisiopatologia , Neuroglia/metabolismo , Óxido Nítrico Sintase/efeitos dos fármacos , Óxido Nítrico Sintase/metabolismo , Ratos , Fator de Necrose Tumoral alfa/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA